1.
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices
by Robinson, Bruce M, Dr
The Lancet (British edition), 2016, Vol.388 (10041), p.294-306
2.
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
by Ortiz, Alberto, Prof
The Lancet (British edition), 2014, Vol.383 (9931), p.1831-1843
3.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
4.
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
by Niewczas, Monika A
Nature medicine, 2019, Vol.25 (5), p.805-813
5.
Worldwide access to treatment for end-stage kidney disease: a systematic review
by Liyanage, Thaminda, MBBS
The Lancet (British edition), 2015, Vol.385 (9981), p.1975-1982
6.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661
7.
Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
by Soliman, Elsayed Z., MD, MSc, MS
The American heart journal, 2010, Vol.159 (6), p.1102-1107
8.
Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study
by Rebholz, Casey M
American journal of nephrology, 2016, Vol.42 (6), p.427-435
9.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181
10.
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Co...
by Orchard, T. J
Diabetologia, 2010, Vol.53 (11), p.2312-2319
11.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019, Vol.25 (11), p.1753-1760
12.
Strategies for long-term preservation of kidney graft function
by Wekerle, Thomas, Prof
The Lancet (British edition), 2017, Vol.389 (10084), p.2152-2162
13.
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
by Palmer, Suetonia C, PhD
The Lancet (British edition), 2015, Vol.385 (9982), p.2047-2056
15.
Lupus Nephritis and End-stage Kidney Disease
by Maroz, Natallia, MD
The American journal of the medical sciences, 2013, Vol.346 (4), p.319-323
16.
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in R...
by Skali, Hicham, MD, MSc
The American heart journal, 2011, Vol.162 (3), p.548-554
17.
AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
by Canaud, Guillaume
Nature medicine, 2013, Vol.19 (10), p.1288-1296
18.
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
by Group, Sharp Collaborative
The American heart journal, 2010, Vol.160 (5), p.785-794.e10
19.
Chronic kidney disease: the global challenge
by El Nahas, A Meguid
Lancet, 2005, Vol.365 (9456), p.331-340
20.
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
by Mocroft, Amanda
AIDS (London), 2010, Vol.24 (11), p.1667-1678
